Cubist Systematic Strategies’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,654
| Closed | -$128K | – | 3736 |
|
|
2023
Q4 | $128K | Buy |
+4,654
| New | +$284K | ﹤0.01% | 3124 |
|
|
2023
Q3 | – | Sell |
-18,674
| Closed | -$1.23M | – | 3359 |
|
|
2023
Q2 | $1.23M | Buy |
+18,674
| New | +$1.37M | 0.01% | 1834 |
|
|
2023
Q1 | – | Sell |
-3,623
| Closed | -$501K | – | 3917 |
|
|
2022
Q4 | $501K | Sell |
3,623
-19,065
| -84% | -$2.69M | ﹤0.01% | 3015 |
|
|
2022
Q3 | $2.87M | Buy |
22,688
+17,910
| +375% | +$2.03M | 0.02% | 1634 |
|
|
2022
Q2 | $396K | Sell |
4,778
-1,252
| -21% | -$97.1K | ﹤0.01% | 3236 |
|
|
2022
Q1 | $585K | Buy |
+6,030
| New | +$796K | ﹤0.01% | 2434 |
|
|
2021
Q4 | – | Sell |
-6,638
| Closed | -$1.64M | – | 3461 |
|
|
2021
Q3 | $1.64M | Sell |
6,638
-5,156
| -44% | -$1.47M | 0.02% | 1171 |
|
|
2021
Q2 | $4.89M | Sell |
11,794
-460
| -4% | -$182K | 0.06% | 551 |
|
|
2021
Q1 | $4.79M | Buy |
12,254
+3,315
| +37% | +$1.63M | 0.06% | 478 |
|
|
2020
Q4 | $5.01M | Buy |
8,939
+6,806
| +319% | +$4.31M | 0.07% | 441 |
|
|
2020
Q3 | $1.49M | Buy |
2,133
+886
| +71% | +$691K | 0.02% | 1085 |
|
|
2020
Q2 | $986K | Sell |
1,247
-5,185
| -81% | -$3.91M | 0.02% | 1185 |
|
|
2020
Q1 | $3.83M | Buy |
6,432
+4,265
| +197% | +$4.16M | 0.1% | 236 |
|
|
2019
Q4 | $2.46M | Buy |
2,167
+705
| +48% | +$766K | 0.05% | 629 |
|
|
2019
Q3 | $1.74M | Sell |
1,462
-1,922
| -57% | -$2.94M | 0.03% | 687 |
|
|
2019
Q2 | $5.58M | Buy |
3,384
+3,052
| +919% | +$5.28M | 0.1% | 265 |
|
|
2019
Q1 | $677K | Sell |
332
-310
| -48% | -$546K | 0.02% | 989 |
|
|
2018
Q4 | $825K | Buy |
642
+637
| +12,740% | +$977K | 0.04% | 656 |
|
|
2018
Q3 | $9K | Sell |
5
-1,848
| -100% | -$3.82M | ﹤0.01% | 1824 |
|
|
2018
Q2 | $3.77M | Buy |
1,853
+898
| +94% | +$2.05M | 0.19% | 118 |
|
|
2018
Q1 | $2.11M | Buy |
955
+805
| +537% | +$2.05M | 0.12% | 207 |
|
|
2017
Q4 | $346K | Buy |
+150
| New | +$305K | 0.02% | 1150 |
|
|
2017
Q3 | – | Sell |
-189
| Closed | -$257K | – | 1846 |
|
|
2017
Q2 | $257K | Buy |
+189
| New | +$228K | 0.02% | 1144 |
|
|
2017
Q1 | – | Sell |
-54
| Closed | -$43K | – | 1636 |
|
|
2016
Q4 | $43K | Buy |
54
+31
| +135% | +$24.6K | ﹤0.01% | 1595 |
|
|
2016
Q3 | $20K | Buy |
23
+1
| +5% | +$724 | ﹤0.01% | 1617 |
|
|
2016
Q2 | $13K | Sell |
22
-2,946
| -99% | -$1.67M | ﹤0.01% | 1649 |
|
|
2016
Q1 | $1.63M | Buy |
2,968
+1,000
| +51% | +$614K | 0.09% | 284 |
|
|
2015
Q4 | $1.64M | Sell |
1,968
-1,105
| -36% | -$1.1M | 0.1% | 278 |
|
|
2015
Q3 | $3.41M | Buy |
3,073
+2,111
| +219% | +$3.85M | 0.17% | 92 |
|
|
2015
Q2 | $2.1M | Sell |
962
-6
| -0.6% | -$12.2K | 0.1% | 256 |
|
|
2015
Q1 | $1.51M | Buy |
968
+948
| +4,740% | +$1.25M | 0.07% | 393 |
|
|
2014
Q4 | $23K | Buy |
+20
| New | +$13.4K | ﹤0.01% | 1817 |
|
Other funds holding BLUE
GIM
PAI
TCM
Cubist Systematic Strategies's BLUE Position: Q1 2024 in Review
Cubist Systematic Strategies sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 4,654 shares — an estimated $128K sold.
Cubist Systematic Strategies first reported a position in BLUE in Q4 2014 and held it in 32 quarters. The position peaked at $5.58M in Q2 2019. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.
- Cubist Systematic Strategies reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 4,654 bluebird bio shares in Q1 2024, an estimated $128K.
- Cubist Systematic Strategies first reported a position in bluebird bio in Q4 2014 and held it in 32 quarters.
- Cubist Systematic Strategies's bluebird bio position peaked at $5.58M in Q2 2019.
- 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.
Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.